Solving Vaccine Challenges through Collaboration

From early phase development to large-scale production, vaccine manufacturers are concerned with balancing speed-to-market and cost while maintaining product safety. Get our eBook, “Solving Vaccine Challenges Together,” and learn how our process development engineers, regulatory experts, and comprehensive portfolio of products and services can help you meet your process goals and challenges, including:

• Achieving higher product yields
• Increasing your process efficiency and product recovery
• Ensuring process safety and reproducibility from batch to batch

Learn how we can help you meet your process goals and challenges

Contact us today to discuss your needs with a technical representative, and discover new solutions for better, faster, safer vaccine development.

Please provide the required * information below.

Featured Articles

We are committed to partnering with academia, organizations and other companies to accelerate vaccine development and ultimately increase access globally. Our collaborations with worldwide vaccine developers and researchers include:

• Leveraging previous efforts at an adenovirus-based vaccine platform for rapid development of a Covid-19 vaccine platform (read more)
• Building on previous collaborations with the Baylor College of Medicine to optimize production of two Covid-19 vaccine candidates (read more)
• Joining the DiViNe Consortium in Europe to address low yields and high costs of vaccine purification (read our white paper)
• Developing optimized purification processes with the International Vaccine Institute (read more)
• Receiving a grant from the Bill & Melinda Gates Foundation as part of a consortium pursuing a new manufacturing platform that would radically increase vaccine availability and affordability in developing countries (read more)

Contact us today to discuss your needs with a technical representative, and discover new solutions for better, faster, safer vaccine development. Or listen to our GEN Podcast, “Vaccinating the World One Collaboration at a Time.”